Back
BioStem Technologies Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
63
BSEM
BioStem Technologies
Last Price:
17.21
Seasonality Move:
-4%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...BioStem Technologies Price Quote
$17.21
0.00 (5.93%)
(Updated: December 14, 2024 at 5:26 AM ET)
BioStem Technologies Key Stats
Buy
63
BioStem Technologies (BSEM)
is a Buy
Day range:
$16.00 - $17.44
52-week range:
$4.28 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
60.7K
Avg. volume:
96.5K
1-year change:
271.76%
Market cap:
$281.3M
Revenue:
$0
EPS:
$-0.48
How Much Does BioStem Technologies Make?
-
How Much Are BioStem Technologies's Sales Annually?
BSEM Revenues are $0 -
How Much Profit Does BioStem Technologies's Make A Year?
BSEM net income is $0
Is BioStem Technologies Growing As A Company?
-
What Is BioStem Technologies's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.3% -
What Is BioStem Technologies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioStem Technologies Stock Price Performance
-
Did BioStem Technologies Stock Go Up Last Month?
BioStem Technologies share price went down by -26.3% last month -
Did BSEM's Share Price Rise Over The Last Year?
BSEM share price rose by 271.76% over the past 1 year
What Is BioStem Technologies 52-Week High & Low?
-
What Is BioStem Technologies’s 52-Week High Share Price?
BioStem Technologies has traded as high as $28.26 over the past 52 weeks -
What Is BioStem Technologies’s 52-Week Low Share Price?
BioStem Technologies has traded as low as $4.28 over the past 52 weeks
BioStem Technologies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioStem Technologies?
-
How Much Debt Does BioStem Technologies Have?
Total long term debt quarterly is $6M -
How Much Cash Does BioStem Technologies Have?
Cash and short term investments quarterly total is $109.9K -
What Is BioStem Technologies’s Book Value Per Share?
Book value per share is -0.26
Is BioStem Technologies Cash Flow Positive?
Data Unavailable
BioStem Technologies Return On Invested Capital
-
Is Management Doing A Good Job?
BSEM return on invested capital is -426.43% -
What Is BioStem Technologies Return On Assets?
ROA measures how assets are converting to revenues and is -139.02% -
What Is BSEM Return On Equity?
ROE is a measure of profitability and is 0%
BioStem Technologies Earnings Date & Stock Price
-
What Is BioStem Technologies's Stock Price Today?
A single share of BSEM can be purchased today for 17.21 -
What Is BioStem Technologies’s Stock Symbol?
BioStem Technologies trades on the otcm under the ticker symbol: BSEM -
When Is BioStem Technologies’s Next Earnings Date?
The next quarterly earnings date for BioStem Technologies is scheduled on December 15, 2024 -
When Is BSEM's next ex-dividend date?
BioStem Technologies's next ex-dividend date is December 15, 2024 -
How To Buy BioStem Technologies Stock?
You can buy BioStem Technologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioStem Technologies Competitors
-
Who Are BioStem Technologies's Competitors?
Below is a list of companies who compete with BioStem Technologies or are related in some way:
BioStem Technologies Dividend Yield
-
What Is BSEM Dividend Yield?
BioStem Technologies’s dividend yield currently is 0% -
What Is BioStem Technologies’s Payout Ratio?
BioStem Technologies’s payout ratio is 0% -
When Did BioStem Technologies Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is BioStem Technologies’s Dividend Per Share?
BioStem Technologies pays a dividend of $0.00 per share
BioStem Technologies Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -5.17% |
| Revenue: | 29.53% | 5.57% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 32.50 |
| Upside from Last Price: | 88.82% |
Major Shareholders
Data Unavailable